Topical Minoxidil for Female Pattern Hair Loss: Clinical Outcomes in Postmenopausal Women

BACKGROUND: Female pattern hair loss (FPHL) affects up to 50% of women and becomes increasingly prevalent after menopause. Declining estrogen levels, altered hormonal balance, and follicular miniaturization contribute to disease progression, which can substantially impair quality of life (QoL). OBJECTIVE: The aim of this study was to review the pathophysiology and psychosocial impact of FPHL, discuss patient counseling and treatment expectations, and evaluate the benefits of topical minoxidil in postmenopausal women. METHODS: Published evidence on FPHL pathophysiology, psychosocial outcomes, treatment barriers, and minoxidil efficacy and tolerability was searched for online using Google and via PubMed. Publications were reviewed for relevance based on the objectives as listed above before being selected for inclusion in our narrative. Findings from a post hoc subgroup analysis of postmenopausal women in a phase III clinical trial of once-daily 5% minoxidil topical foam (MTF) were also assessed. RESULTS: FPHL is influenced by genetic susceptibility, aging, and menopausal hormonal changes. Hair loss is associated with reduced self-esteem, social withdrawal, anxiety, and impaired QoL. Delayed treatment initiation is common. In a phase III study, 5% MTF significantly increased hair count versus vehicle at 24 weeks. Post hoc analyses demonstrated significant hair regrowth in postmenopausal women with both early and advanced hair loss. CONCLUSION: Once-daily 5% MTF is effective in postmenopausal women regardless of disease severity. Early recognition, patient education, individualized treatment selection, and psychosocial support are essential for optimal outcomes.

Authors

Publication Details

Journal
Dermatologic Surgery
Published
2026-11-19
DOI
https://doi.org/10.1097/dss.0000000000005472
Primary Topic
Hair Growth and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Topical Minoxidil for Female Pattern Hair Loss: Clinical Outcomes in Postmenopausal Women

Nicole E. Rogers, Ramond J. Waide, Payvand Kamrani, Deirdre Hooper et al.
1 links
Dermatologic Surgery
Hair Growth and Disorders
article

Topical Minoxidil for Female Pattern Hair Loss: Clinical Outcomes in Postmenopausal Women

Nicole E. Rogers, Ramond J. Waide, Payvand Kamrani, Deirdre Hooper, Asha Patel Shah, Hsiao-Pin Liu
article en

Abstract

BACKGROUND: Female pattern hair loss (FPHL) affects up to 50% of women and becomes increasingly prevalent after menopause. Declining estrogen levels, altered hormonal balance, and follicular miniaturization contribute to disease progression, which can substantially impair quality of life (QoL). OBJECTIVE: The aim of this study was to review the pathophysiology and psychosocial impact of FPHL, discuss patient counseling and treatment expectations, and evaluate the benefits of topical minoxidil in postmenopausal women. METHODS: Published evidence on FPHL pathophysiology, psychosocial outcomes, treatment barriers, and minoxidil efficacy and tolerability was searched for online using Google and via PubMed. Publications were reviewed for relevance based on the objectives as listed above before being selected for inclusion in our narrative. Findings from a post hoc subgroup analysis of postmenopausal women in a phase III clinical trial of once-daily 5% minoxidil topical foam (MTF) were also assessed. RESULTS: FPHL is influenced by genetic susceptibility, aging, and menopausal hormonal changes. Hair loss is associated with reduced self-esteem, social withdrawal, anxiety, and impaired QoL. Delayed treatment initiation is common. In a phase III study, 5% MTF significantly increased hair count versus vehicle at 24 weeks. Post hoc analyses demonstrated significant hair regrowth in postmenopausal women with both early and advanced hair loss. CONCLUSION: Once-daily 5% MTF is effective in postmenopausal women regardless of disease severity. Early recognition, patient education, individualized treatment selection, and psychosocial support are essential for optimal outcomes.

Dermatologic Surgery
Good health and well-being
Hair Growth and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon